Compositions comprising sphingosine 1 phosphate (S1P) receptor modulators

Details for Australian Patent Application No. 2008310846 (hide)

Owner Novartis AG

Inventors Ambuhl, Michael; Ruegger, Colleen

Agent Davies Collison Cave

Pub. Number AU-B-2008310846

PCT Pub. Number WO2009/048993

Priority 60/979,482 12.10.07 US

Filing date 9 October 2008

Wipo publication date 16 April 2009

Acceptance publication date 21 June 2012

International Classifications

A61K 47/00 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/048993 Priority application(s): WO2009/048993

21 June 2012 Application Accepted

  Published as AU-B-2008310846

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008310852-Implant magnet insertion and removal tools

2008310843-Methods and systems for controlled deployment of needles in tissue